Faron Pharmaceuticals Oy (AIM:FARN)
London · Delayed Price · Currency is GBP · Price in GBX 180.00
0.00 (0.00%)
Dec 31, 2025, 11:58 AM GMT+1
Faron Pharmaceuticals Oy Market Cap
Faron Pharmaceuticals Oy has a market cap or net worth of 205.02 million as of December 31, 2025. Its market cap has increased by 15.27% in one year.
Market Cap
205.02M
Enterprise Value
212.63M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
180.00
Market Cap Chart
Since November 17, 2015, Faron Pharmaceuticals Oy's market cap has increased from 53.46M to 205.02M, an increase of 283.50%. That is a compound annual growth rate of 14.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 205.02M | -4.41% |
| Dec 31, 2024 | 214.48M | 2.23% |
| Dec 29, 2023 | 209.80M | 16.93% |
| Dec 30, 2022 | 179.42M | 26.00% |
| Dec 31, 2021 | 142.40M | 16.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 213.19B |
| GSK plc | 73.15B |
| Haleon | 33.22B |
| Smith & Nephew | 10.43B |
| Convatec Group | 4.74B |
| Hikma Pharmaceuticals | 3.40B |
| Genus | 1.73B |
| HUTCHMED (China) | 1.71B |